Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

430.14

+4.13 (0.97%)

At close: Apr 28, 2026, 4:00 PM EDT

427.88

-2.26 (-0.53%)

After-hours: Apr 28, 2026, 5:42 PM EDT

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $109.41 billion as of April 28, 2026. Its market cap has decreased by -10.39% in one year.

Market Cap

109.41B

Enterprise Value

98.96B

1-Year Change

-10.39%

Ranking

#143

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $109.41B, an increase of 17,792.12%. That is a compound annual growth rate of 20.82%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	108.22B	-5.92%
Dec 31, 2025	115.03B	10.91%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Regeneron Pharmaceuticals	76.46B
argenx SE	48.50B
Alnylam Pharmaceuticals	40.52B
BeOne Medicines AG	33.36B
Royalty Pharma	29.27B
Insmed	29.18B
Revolution Medicines	28.46B
BioNTech SE	26.67B

Market Cap Rankings